Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients.


OBJECTIVE Detection of preclinical hypertension-related cardiorenal damage has been recommended in the identification of patients most at risk of cardiovascular complications. The inclusion of silent cerebrovascular disease (SCD) as an additional marker of hypertensive organ involvement might improve risk stratification. METHODS In 192 hypertensive… (More)
DOI: 10.1097/HJH.0b013e3283232c96